IL1B and pneumonia: To further evaluate the efficiency of the phages in treating pneumonia, we examined the concentrations of cytokines, including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor alpha (TNF-α), and pathological injuries at 24 and 48 h postinfection.